Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role
Open Access
- 1 January 2013
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 7, 74
Abstract
The opioid peptide receptors consist of three major subclasses, namely, μ, δ, and κ (MOR, DOR, and KOR, respectively). They are involved in the regulation of striatal dopamine functions, and increased opioid transmissions are thought to play a compensatory role in altered functions of the basal ganglia in Parkinson's disease (PD). In this study, we used an immunohistochemistry with tyramide signal amplification (TSA) protocols to determine the distributional patterns of opioid receptors in the striosome-matrix systems of the rat striatum. As a most striking feature of striatal opioid anatomy, MORs are highly enriched in the striosomes and subcallosal streak. We also found that DORs are localized in a mosaic pattern in the dorsal striatum (caudate-putamen), with heightened labeling for DOR in the striosomes relative to the matrix compartment. In the 6-hydroxydopamine-lesioned rat model of PD, lesions of the nigrostriatal pathways caused a significant reduction of striatal labeling for both the MOR and DOR in the striosomes, but not in the matrix compartment. Our results suggest that the activities of the striosome and matrix compartments are differentially regulated by the opioid signals involving the MORs and DORs, and that the striosomes may be more responsive to opioid peptides (e.g., enkephalin) than the matrix compartment. Based on a model in which the striosome compartment regulates the striatal activity, we propose a potent compensatory role of striosomal opioid signaling under the conditions of the striatal dopamine depletion that occurs in PD.Keywords
This publication has 62 references indexed in Scilit:
- Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in miceFrontiers in Cellular Neuroscience, 2013
- Ubiquitination in the First Cytoplasmic Loop of μ-Opioid Receptors Reveals a Hierarchical Mechanism of Lysosomal Down-regulationJournal of Biological Chemistry, 2011
- Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix CompartmentsFrontiers in Neuroanatomy, 2011
- The Role of Ubiquitination in Lysosomal Trafficking of δ‐Opioid ReceptorsTraffic, 2010
- Multiple Timescales of Memory in Lateral Habenula and Dopamine NeuronsNeuron, 2010
- Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapyProceedings of the National Academy of Sciences, 2009
- Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystoniaProceedings of the National Academy of Sciences, 2008
- Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing μ-opioid receptor in ratsNeuroscience Letters, 2002
- Delta opioid receptor mRNA distribution in the brain: Comparison to delta receptor binding and proenkephalin mRNAJournal of Chemical Neuroanatomy, 1993
- Nigral 6-hydroxydopamine lesions equally decrease μ and δ opiate binding to striatal patches: Further evidence for a conformationally malleable type 1 opiate receptorLife Sciences, 1982